New Echocardiographic Parameters for Assessment of Longitudinal Left Ventricular Function
NCT ID: NCT01275963
Last Updated: 2016-11-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
400 participants
OBSERVATIONAL
2011-01-31
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to evaluate new echocardiographic parameters for longitudinal left ventricular function. A special focus is set on strain imaging by speckle tracking, which is a relatively new technique. Patients with different cardiac pathologies (e. g. dilated cardiomyopathy, coronary artery disease, diastolic dysfunction) will be included and compared to healthy individuals.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Healthy individuals without structural heart disease
No interventions assigned to this group
CAD
Patients with coronary artery disease
No interventions assigned to this group
DCM
Participants with dilated cardiomyopathy
No interventions assigned to this group
HNCM
Patients with hypertrophic non-obstructive cardiomyopathy
No interventions assigned to this group
HOCM
Patients with hypertrophic obstructive cardiomyopathy
No interventions assigned to this group
RCM
Patients with restrictive cardiomyopathy
No interventions assigned to this group
Amyloidosis
Patients with cardiac manifestation of amyloidosis
No interventions assigned to this group
HFPEF
Patients with heart failure with preserved ejection fraction (diastolic heart failure)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* written consent
Exclusion Criteria
* moderate/severe valvular heart disease
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heidelberg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Derliz Mereles
Dr. Derliz Mereles
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthias Aurich, M.D.
Role: PRINCIPAL_INVESTIGATOR
Heidelberg University
Derliz Mereles, M.D.
Role: PRINCIPAL_INVESTIGATOR
Heidelberg University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Heidelberg
Heidelberg, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Aurich M, Keller M, Greiner S, Steen H, Aus dem Siepen F, Riffel J, Katus HA, Buss SJ, Mereles D. Left ventricular mechanics assessed by two-dimensional echocardiography and cardiac magnetic resonance imaging: comparison of high-resolution speckle tracking and feature tracking. Eur Heart J Cardiovasc Imaging. 2016 Dec;17(12):1370-1378. doi: 10.1093/ehjci/jew042. Epub 2016 Mar 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
S-401/2010
Identifier Type: -
Identifier Source: org_study_id